Additionally, knockdown of PEPCK2 or G6P resulted in a significant reduction of tumor growth (Figure 2C), whereas PEPCK1 or FBP knockdown tended to reduce—although not significantly—tumor growth (Figure 2C). The gene discussed is PCK2; the disease is neoplasm.